The potential applications of PBMT are numerous and are being explored experimentally at the basic science, pre-clinical and clinical level. The current clinical uses are for the relief of pain and inflammation and the treatment of sports injuries. PBMT devices have been approved by the FDA to stimulate hair growth and decrease fat deposits.
About Photobiomodulation (PBM)
is the term used to describe the mechanistic/scientific basis for this photonic specialty and photobiomodulation therapy (PBMT) as the term for its therapeutic application. Treatment of diseases utilizing phototherapy won the first of many Nobel Prizes awarded in this field in 1903. In 1960, the first laser was developed, which led to the first documentation of accelerated healing in veterinary medicine in 1967. By the early 1970's, laser therapy was recognized as a physical therapy modality in Eastern Europe and China. During the early years, this emerging photonic application was plagued by a number of problems including inconsistent terminology.
A number of terms were introduced such as Biostimulation, Cold/Cool Laser, Low Level laser therapy, Soft Laser and Low Power Laser Therapy. Based on recent consensus in the field, PBM and PBMT are now considered the terms of choice.
In 2015 thanks to the efforts of Dr. Praveen Arany, PBMT was added to the National Library of Medicine MeSH database as an entry term to the existing record of laser therapy, low-level
